events, campaigns & more Sign Up
In the Headlines
Abeona Therapeutics gets FDA clearance to proceed with Phase 3 clinical trial of its EB-101 cell
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.